Parvovirus B19 infection leads to transient aplastic crises in individuals with chronic hemolytic anemias or immunodeficiency states. An additional unexplained sequela of 619 infection is thrombocytopenia. Because 61 9 is known to have a remarkable tropism for human erythropoietic elements, and is not known to replicate in nonerythroid cells, the etiology of this thrombocytopenia is uncertain. We sought to define the pathobiology of 619-associated thrombocytopenia by examining the role of 619 on in vitro megakaryocytopoiesis. B19 infection of normal human bone marrow cells significantly suppressed megakaryocyte (MK) colony formation compared with mock-infected cells. No such inhibition was observed with a nonpathogenic human parvovirus, the adeno-associated virus 2 (AAV).
Parvovirus B19 infection leads to transient aplastic crises in individuals with chronic hemolytic anemias or immunodeficiency states. An additional unexplained sequela of 619 infection is thrombocytopenia. Because 61 9 is known to have a remarkable tropism for human erythropoietic elements, and is not known to replicate in nonerythroid cells, the etiology of this thrombocytopenia is uncertain. We sought to define the pathobiology of 619-associated thrombocytopenia by examining the role of 619 on in vitro megakaryocytopoiesis. B19 infection of normal human bone marrow cells significantly suppressed megakaryocyte (MK) colony formation compared with mock-infected cells. No such inhibition was observed with a nonpathogenic human parvovirus, the adeno-associated virus 2 (AAV).
The 619-MK cell interaction was also studied at the molecular level, Whereas low-density bone marrow cells containing erythroid precursor cells supported 61 (MK) leads to thrombocytopenia prompted the present studies. We addressed this question directly by examining the role of B19 on in vitro megakaryocytopoiesis. Our data suggest that B19 infection can impair in vitro megakaryocytopoiesis. This effect may contribute to the development of thrombocytopenia in individuals infected with parvovirus B19.
MATERIALS AND METHODS

Viruses and hematopoietic growth factors.
A source of parvovirus B19 (Minor 11) was generously provided by Dr N.S. Youzg, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. A serum sample obtained from a patient with sickle cell anemia experiencing an aplastic crisis served as this replication, no viral DNA replication was observed in B1 9-infected MK-enriched fractions as determined by the presence of viral DNA replicative intermediates on Southern blots. However, analysis of total cytoplasmic RNA isolated from 619-infected MK fractions showed a lowlevel expression of the B19 genome as detected by quantitative RNA dot blots as well as by Northern analysis. Furthermore, a frame-shift mutation in a recombinant AAV-B19 hybrid genome segment that encodes the viral nonstructural (NSI 1 protein significantly reduced the observed inhibition of MK colony formation. These studies indicate tissue-tropism of B19 beyond the erythroid progenitor cell, and lend support to the hypothesis that B19 genome expression may be toxic to cell populations that are nonpermissive for viral DNA replication. 0 1990 by The American Society of Hematology.
sou~ce.~ The virus was propagated in fresh human bone marrow cultures in vitro as described previ~usly.'~-~~ Subsequently, an additional source of parvovirus B19 (SH) was obtained from the serum of a patient with sickle cell anemia at a time when she was experiencing an aplastic crisis at the Indiana University Hospitals, Indianapolis. The human adeno-associated virus 2 (AAV)27 and the human adenovirus type 2 (Ad 2)28 were kindly supplied by Drs K.I. Berns, Cornell University Medical College, New York, NY, and K.H. Fife, Indiana University School of Medicine, Indianapolis, respectively. AAV and Ad2 were propagated in human KB cells as described previo~sly.~~ Recombinant human interleukin-3 (rIL-3, specific activity 3.5 x lo5 colony forming units [CFU]/pg) and recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF, specific activity 2.5 x 10' CFU/pg) were purchased from the Genzyme Corp, Boston, MA.
A near fulllength B19 genomic DNA cloned into plasmid ~Y T 1 0 3 *~ was a kind gift from Dr P. Tattersall, Yale University, New Haven, CT. Plasmid clones of AAV (psub201 and PAAV/A~)'~~" were generously provided by Dr R.J. Samulski, University of Pittsburgh, Pittsburgh, PA. We have recently described the construction of a recombinant AAV-B19 hybrid genome ~A S 3 1 3 .~~ To construct a frame-shift mutation in the NS1 gene of B19," the plasmid pAS313 DNA was digested to completion with Xba I restriction endonu-clease, the ends were blunted with Klenow DNA polymerase and subsequently religated to generate a plasmid pAS313Xba-. Plasmids pAS313 and pAS313Xba-were transfected separately into AdZinfected KB cells together with pAAV/Ad, and the progeny virions were isolated essentially as described previo~sly.'~ A human y-actin probe was obtained from Dr Winston Saker, University of California, Los Angeles.
Bone marrow cells were obtained from hematologically normal volunteer donors after informed consent was obtained according to guidelines established by the Human Investigation Committee of the Indiana University School of Medicine. Low-density (LD < 1.077 g/mL) cells were isolated by means of Ficoll-Hypaque density gradient centrifugation.'' Cell fractions highly enriched for human MK were isolated by density centrifugation and counterflow centrifugal elutriation as described by Berkow et ai.'' Briefly, low-density mononuclear cells were collected, washed, and injected into a Beckman elutriator system with a standard separation chamber (Beckman Instruments Inc, Palo Alto, CA). After loading, the flow rate was maintained at 9.5 mL/min with a rotor speed of 1,950 rpm, and 200 mL of effluent was collected. The flow rate was increased in 1 or 2 mL/min increments, and 100 mL of effluent was collected at each increment until a flow rate of 32.5 mL/min was achieved. At this point, the rotor was stopped and the separation chamber was removed and flushed to collect all residual cells (final fraction). The final fraction which contains 16% to 25% MK,33 was used in these studies.
In some experiments, marrow fractions enriched for MK progenitor cells according to the method of Lu et were used. Briefly, LD bone marrow mononuclear cells were first separated into nonadherent (NAL) and adherent cells. The NAL cells were further separated by E-rosetting to isolate the nonadherent, T-cell-depleted (NALT-) cell population as previously NALT-cells were further fractionated by two-color sorting using two monoclonal antibodies (MoAbs), the mouse anti-HPCA-1 (MylO), and the mouse anti-MHC class I1 (HLA-DR, clone L243, conjugated with phycoerythrin; Becton Dickinson Co, Sunnyvale, CA). Cells were incubated in sequence at saturating levels of My 10, biotinylated goat anti-mouse Immunoglobulin G (IgG) (Vector Laboratories, Inc,
Cells and cell separation procedures.
Burlingame, CA), Texas Red Avidin D, mouse serum, and, finally, mouse anti-HLA-DR. Cells were sorted on a Coulter Epics 753 Dye Laser Flow Cytometry System (Coulter Electronics, Hialeah, FL) to isolate cell fractions with low-level expression of CD34 and HLA-DR antigens (CD34+DR+) as described previ~usly.'~~'~ Serum-depleted assays for hematopoietic colony formation. rIL-3 and rGM-CSF were used to promote MK colony formation by LD or CD34+DR+ marrow cells in a serum-depleted fibrin clot culture system as described by Bruno et a1.36337 Briefly, mockinfected or parvovirus-infected LD marrow cells or CD34+DR+ cells were incubated in the presence of IL-3 in triplicate or quadruplicate for 12 days at 37OC in a 100% humidified atmosphere of 5% CO, in air. After incubation, fibrin clots were fixed in situ in methanol: acetone (1:3) for 20 minutes, washed with 0.01 mol/L phosphatebuffered saline (PBS, pH 7.2), followed by double-distilled water, and then air-dried. Fixed cells were stored frozen at -2OOC until immunofluorescent staining was performed. Burst forming uniterythroid (BFU-E) and colony forming unit-erythroid (CFU-E) assays were performed as described previ~usly.''~'~ Immunofluorescent identification of human MK colonies. Rabbit antisera to human platelet glycoprotein was used as an immunologic probe for identifying human MK as described pre~iously.'"~'~
The results of hematopoietic colony assays were expressed as the mean f standard error of the mean (SEM) of data obtained from three or more separate experiments performed in duplicate or quadruplicate. Statistical significance was determined by using the Student's t test.
Isolation of low-molecular-weight DNA and Southern blot analysis. Mock-infected and B19-infected low-density normal bone marrow (NBM) cells, and the B19-infected MK-enriched fraction (MK-Fr) cells were grown either in the absence or presence of erythropoietin (Epo). Low-molecular-weight DNA samples were isolated by a modification of the method described by Hirt.39.40 Briefly, cells were harvested, washed with PBS, and lysed in a solution containing 10 mmol/L Tris-HC1, pH 7.5,5 mmol/L EDTA and 0.5% sodium dodecyl sulfate (SDS). After 10 minutes of incubation at room temperature, NaCl was added to a final concentration of 0.6 mol/L. Solutions were mixed well and incuStatistical analysis. Schleicher and Schuell. Keene. NH) by the method described by Southern" and probed with a "P-labeled pYT103 B19 DNA insert probe radioactively labeled to specific activity exceeding I x IO9 cpm/pg DNA by the random hexanucleotide primer labeling method described by Feinberg and Vogelstcin." Filters were hybridized at 42OC in 5 x SSC (standard saline citrate) containing 50% formamide essentially as described previousIy."~" Filters were washed under stringent conditions (0. I x SSC. 68OC) and autoradiographed using Kodak XAR-5 autoradiographic film (Kodak Chemical Co. Rochester. NY) at -7OOC. Uninfccted and BI9-infected NBM and MK-Fr cells grown in the absence or presence of Epo were washed with PBS. and cytoplasmic RNA was isolated according to the method described by White and Bancroft."
Briefly, cells were incubated in 10 mmol/L fris-1 mmol/L EDTA, pH 7.0. on ice for IO minutes and lysed with the addition of 5% NP-40. Cell lysates were centrifuged at 15.000g for 2.5 minutes to pellet the nuclei, the clear cytoplasmic fractions were collected. and an q u a l volume of freshly prepared solution of 20 x SSC:37% formaldehyde (3:2) was added. Following incubation at 6OOC for I5 minutes, twofold serial dilutions of the denatured cytoplasmic RNA were filtered through nitrocellulose filters using a Dot Blot apparatus (Bio Rad Laboratories. Richmond, CA). Equivalent aliquots of cytoplasmic fractions with or without prior digestion with 100 pg/mL RNase A. were similarly processad and probed with the B19 DNA probe and autoradiographed as described above.
Norrhern analysis. Total cellular RNA was isolated from lowdensity normal bone marrow and MK-Fr cells using the guanidinium thiocyanate lysis and phenol-chloroform extraction method described by Chomczynski and Sacchi.' ' Approximately 3 pg of RNA samples were fractionated on a I .2% agarose gel containing 6.7% formaldehyde and transferred to a nylon membrane (Msi Magna Nylon 66. Fisher Scientific Co. Cincinnati. OH) in 20 x SSC. The membrane was prehybridized and hybridized as described by Church and Gilbert," except that hybridization was performed at 42OC in the presence of 50% formamide. A B I9-spocific probe was labeled and used as described above. Following autoradiography, the same Isolation of cytoplasmic RNA and dot blor analysis.
blot was stripped of the B19 probe and hybridized with a human y-actin probe.
RESULTS
Efecr of parvovirus 819 infecrion on human megakaryocytopoiesis in virro. LD normal bone marrow cells were either mock-infected. infected with parvovirus B19, or infected with the nonpathogenic human parvovirus, AAV, at 4OC for 2 hours. Cells were washed free of the virus inoculum and assayed for CFU-MK-derived colonies. T h e effect of these pretreatments on CFU-MK cloning efficiency is shown under experiment 1 in Table 1 .
It is evident that whereas AAV-infection of LD cells had no effect on M K colony formation in vitro, B19 infection NBM MH-Fr.
-- For personal use only. on November 10, 2017. by guest www.bloodjournal.org From resulted in significant inhibition of MK colony formation promoted by either IL-3 or GM-CSF. In the next set of experiments, the specificity of B19-induced inhibition of human MK colony formation was assessed and compared with its well-established inhibitory effect on human erythroid colony formation (BFU-E and CFU-E).'5.'9.''.22 LD cells were either mock-infected or exposed to 100 to IO-* dilutions of B19 serum and examined for their ability to form colonies (CFU-MK, BFU-E, and CFU-E). The results are presented under experiment 2 in Table 1 . B19 infection led to significant inhibition of CFU-MK by undiluted B19 serum, the extent of which was similar to the inhibitory effect on CFU-E and BFU-E."." A 10. * dilution of the serum sample caused significant inhibition of CFU-E, whereas CFU-MK and BFU-E colony formation were not significantly affected at this serum concentration. We also examined the effect of parvovirus infection on the ability of CD34'DR+ cells to form M K colonies in vitro. These data are presented in Table  2 . Again, B19 suppressed MK colony formation in the presence of either IL-3 or GM-CSF, whereas AAV infection had no effect.
Parvovirus BI 9 DNA replication in unseparated normal bone marrow cells and MK-enriched fractions. We next examined whether the observed inhibition of MK colony formation was a direct consequence of B19 viral replication in human MK. BIB-infected NBM and MK-Fr cells were maintained in the presence of 1 U/mL Epo for 48 to 72 hours. Low molecular weight DNA was isolated from these cells and analyzed with and without prior digestion with BamHl restriction endonuclease for the presence of the characteristic B19 viral DNA replicative intermediates on Southern blots as described in Materials and Methods. The results are shown in Fig 1. It is evident that whereas NBM cells supported B19 DNA replication (Fig I , lane I) . with the characteristic BamHIdoublets" (lane 2). under identical conditions no detectable B19 DNA replication could be observed in MK-Fr cells (lanes 3 and 4) . Assuming that the number of target cells for B19 infection in NBM (=25% erythroblasts) was roughly identical to those in MK-Fr (=25% megakaryocytes), we To ascertain whether the infected MK-Fr cells contained the previously characterized species of B 19-specific RNA expressed in LD bone marrow cells," we performed a comparative Northern blot analysis. As can be seen in Fig 3. For personal use only. on November 10, 2017. by guest www.bloodjournal.org From studies by Ozawa et alZ5 have documented that the NSI gene product of BI 9 (Fig 4A) is cytotoxic to HeLa cells which are nonpermissive for viral DNA replication and virion accumulation. Because our expression studies suggested that a similar mechanism might account for the observed inhibition of human megakaryocytopoiesis in vitro, we wished to further explore this hypothesis. We have recently described the construction of a recombinant parvovirus B19" which contains the inverted terminal repeats (ITRs) of AAVa and which is biologically indistinguishable from the wild-type B19.'' The availability of a recombinant AAV-B19 hybrid genome allowed us to create a frame-shift mutation" in the NSI gene of parvovirus B19 (Fig 48) . Both the recombinant wild-type (pAS313) and the NSI-mutant (pAS313Xba ) genomes were packaged separately into mature AAV particle^,'^ and were used to infect LD cells before assaying for MK progenitor cells. The results of these experiments are shown in Table 3 .
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As can be seen, whereas the AAV-B19 hybrid virus significantly inhibited MK colony formation, the hybrid virus with a frame-shift mutation in the NSI gene did not significantly alter MK colony formation under identical conditions. Similarly, although the AAV-B19 hybrid virus has been shown to suppress erythropoiesis in vitro," the NSI mutation completely obliterated the inhibition of BFU-E. A 26% inhibition of CFU-E occurred following exposure to the NS1-mutant virus as compared with a 55% inhibition with the wild-type AAV-B19 hybrid virus. Therefore, these data strongly suggest that the R19-induced cytotoxicity to MK progenitor cells is due to the expression of the viral NSI gene.
DISCUSSION
Although parvoviruses in general are ubiquitous in the human pathogenic parvovirus B19 has to date been shown to possess an extremely narrow host-range. For example, the target cells for B19 infection in vitro have been identified as belonging to the erythroid lineage of human hematopoietic cells. The underlying mechanism of such a remarkable tissue-tropism of B19 still remains unexplained. In addition to anemia and reticulocytopenia, thrombocytopenia and neutropenia have been observed following B19 infe~tion.'~.~~ Because B19 is not known to replicate in nonerythroid cell^,'^^'^ the basis for these observations is unclear. Although B19 has been shown not to affect the granulocyte-macrophage lineage of the human hematopoietic ~y s t e m , '~* '~*~' its role in human megakaryocytopoiesis has not been explored. To address the pathobiology of thrombocytopenia associated with B19 infection, we examined the effect of B19 on human in vitro megakaryocytopoiesis. Significant inhibition of MK colony formation by B19 was observed. Interestingly, a nonpathogenic human parvovirus, AAV, had no inhibitory effect. A recent report by Hanada et aI5' reported strong inhibitory effects on CFU-MK-and CFU-GM-derived colony formation by high concentrations of serum obtained from a patient with hereditary spherocytosis, and a B19 infection. Thus, our data lend support to the hypothesis that parvovirus B19 may be cytotoxic not only to erythroid progenitor cells but also to other hematopoietic progenitor cells.
The molecular basis of B19-induced inhibition of human MK colony formation remains unknown. In our experiments, we could not detect B19 DNA replication in marrow cell fractions enriched for human MK. Whether or not B19 DNA replication occurs in MK progenitor cells remains to be examined. Interestingly, however, Ozawa et a125 recently reported a strong cytotoxic effect by the cloned B19 genome following transfection into HeLa cells in the absence of viral DNA replication. The inhibitory effect was shown to be mediated by the NSI gene of B19. In our experiments, we were also able to document complete transcription of the B19 genome in mature MK in the absence of DNA replication. Furthermore, the inhibition of MK colony formation by B19 was thought to be due to the NS1 protein because a frame-shift mutation in the gene that encodes this protein abrogated the observed effect. Similarly, the same frameshift mutation in the NSI gene also eliminated B19-induced inhibition of the BFU-E colony formation. These data suggest that the B19 NS1 gene product may also be the viral rep protein.
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However, the inhibition of the CFU-E colony formation was not completely reversed by this mutation. Because these studies were performed with a recombinant B19 virus containing the AAV ITRs,'l which, in the absence of viral DNA replication, are known to mediate efficient integration of the viral genome with the host chromo~ome,~'-~' it is likely that the viral DNA integration per se is cytotoxic (Srivastava et al, unpublished results).
Our data lend strong support to the hypothesis of Ozawa et aI2j that the NSl-mediated cytotoxicity of megakaryocytes may account for the common clinical occurrence of thrombocytopenia following B19 infection. B19 infection may lead to thrombocytopenia, therefore, not only by inhibiting CFU-MK proliferation, but also by perturbing the number and/or function of mature MK. For personal use only. on November 10, 2017. by guest www.bloodjournal.org From
